Provided by Tiger Fintech (Singapore) Pte. Ltd.

IDEXX Laboratories

648.43
+2.780.43%
Volume:95.80K
Turnover:61.79M
Market Cap:51.88B
PE:53.98
High:648.49
Open:644.59
Low:643.40
Close:645.65
52wk High:688.12
52wk Low:356.14
Shares:80.00M
Float Shares:79.12M
Volume Ratio:1.85
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):12.01
EPS(LYR):10.77
ROE:64.87%
ROA:23.26%
PB:35.56
PE(LYR):60.23

Loading ...

IDEXX Laboratories Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Sep 12

IDEXX Laboratories Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Sep 11

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Sep 09

IDEXX Laboratories Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Sep 05

The companies where investors have the highest hopes and dreams have some predictable, and surprising, results

Dow Jones
·
Sep 03

IDEXX Laboratories Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Sep 03

IDEXX Laboratories Inc. to Participate in Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 03

Director M. Anne Szostak Reports Disposal of Common Shares of IDEXX Laboratories Inc

Reuters
·
Aug 27

IDEXX Laboratories Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Aug 22

IDEXX Laboratories Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Aug 19

IDEXX Labs Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 15

Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $765 From $722, Maintains Overweight Rating

MT Newswires Live
·
Aug 15

IDEXX Laboratories Inc. Executive Vice President Michael G. Erickson Reports Disposal of Common Shares

Reuters
·
Aug 15

IDEXX Laboratories Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Aug 15

Nimrata Hunt, Executive VP, Reports Disposal of Common Shares in IDEXX Laboratories Inc

Reuters
·
Aug 14

Sharon E. Underberg, EVP, GC & Corporate Secretary of IDEXX Laboratories Inc., Reports Disposal of Common Shares

Reuters
·
Aug 13

Piper Sandler Adjusts Price Target on IDEXX Laboratories to $700 From $510, Maintains Neutral Rating

MT Newswires Live
·
Aug 11

IDEXX Laboratories Inc : Piper Sandler Raises Target Price to $700 From $510

THOMSON REUTERS
·
Aug 11

Weekly Winners | Palantir Stock Rockets 21%; Arista Networks Pops 18%; Apple, Micron Surge over 13%

Tiger Newspress
·
Aug 10